Gene: RFTN1
Official Full Name: raftlin, lipid raft linker 1provided by HGNC
Gene Summary: Enables double-stranded RNA binding activity. Involved in B cell receptor signaling pathway; membrane raft assembly; and positive regulation of growth rate. Acts upstream of or within dsRNA transport; response to exogenous dsRNA; and toll-like receptor 3 signaling pathway. Located in endosome; membrane raft; and plasma membrane. Part of protein-containing complex. Biomarker of glaucoma. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29737 | RFTN1 Knockout cell line (HeLa) | Human | RFTN1 | 1:3~1:6 | Negative | Online Inquiry |
KO29738 | RFTN1 Knockout cell line (HCT 116) | Human | RFTN1 | 1:2~1:4 | Negative | Online Inquiry |
KO29739 | RFTN1 Knockout cell line (HEK293) | Human | RFTN1 | 1:3~1:6 | Negative | Online Inquiry |
KO29740 | RFTN1 Knockout cell line (A549) | Human | RFTN1 | 1:3~1:4 | Negative | Online Inquiry |
RFTN1 Gene Knockout Cell Lines are an innovative tool designed to facilitate research into the function and implications of the RFTN1 gene, which plays a pivotal role in various cellular processes, including cell signaling and neural development. These cell lines are created through advanced CRISPR-Cas9 gene-editing technology, effectively disrupting the RFTN1 gene to provide users with a robust model to study gene function and associated phenotypic changes.
The primary mechanism through which RFTN1 knockout cell lines operate is the complete abrogation of RFTN1 gene expression, allowing researchers to investigate the downstream effects on cellular pathways, gene interactions, and protein functionality. By providing a controlled environment free from the influence of this gene, scientists can conduct comparative studies, thereby elucidating the role of RFTN1 in health and disease.
Scientifically, these cell lines are invaluable for both basic and applied research. They enable a detailed examination of RFTN1's involvement in oncogenesis, neurodegenerative diseases, and other critical areas of study. In clinical research, understanding the mechanisms underlying RFTN1 function can pave the way for novel therapeutic strategies, which is crucial for the advancement of personalized medicine.
The RFTN1 Gene Knockout Cell Lines stand out in the market due to their rigorous validation, consistent performance across varied experimental conditions, and the comprehensive support provided by our expert team. Unlike other gene knockout models that may exhibit variable efficiency or lack thorough characterization, our cell lines come with detailed protocols and documentation, ensuring reliable results for researchers.
For professionals in academic and clinical settings, the RFTN1 Gene Knockout Cell Lines represent a significant advancement that not only streamlines research processes but also enhances the potential for breakthrough discoveries. Our company’s commitment to scientific excellence and continued innovation ensures that researchers have access to cutting-edge tools that propel their work forward. With our expertise and dedication, we are proud to contribute to the scientific community by providing superior biological products tailored for impactful research outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.